Oncology Spokane

Stephanie R Moline, MD, FACS

Oncology Spokane
Make an Appointment

Address
601 South Sherman Street
Place
Spokane, WA   99202 
Landline
(509) 228-1000
Fax
(509) 252-9300
E-Mail
[email protected]
Twitter
@CancerCareNW
Facebook
CancerCareNorthwest
Video
meet dr. moline
Website
www.cancercarenorthwest.com
Menu
www.cancercarenorthwest.com

Description

A love for science and service combined with a passion for women’s health led Dr. Moline to the field of breast oncology. Originally from Jackson, MS, Dr. Moline attended University of Alabama where she completed a Bachelor of Science degree in chemistry and mathematics. She went on to earn a medical degree from Vanderbilt University, followed by a general surgery residency at the University of South Alabama. During residency, she focused heavily on breast surgical oncology. Dr. Moline then completed a breast surgical oncology fellowship at University of Michigan. Her specialized fellowship training enables her to perform individualized and unique surgical techniques to treat breast cancer.

Keywords Cancer treatment, oncology, cancer center, surgical oncology, surgical oncologist, cancer doctor, cancer surgery, cancer surgeon, oncologist, breast cancer treatment, breast cancer surgery, mastectomy, partial mastecomy, lumpectomy, cancer clinic, cancer specialists, oncology clinic, cancer care, cancer treatment near me, oncology near me, cancer center near me, oncologist near me, surgical oncology near me, cancer clinic near me, Spokane cancer center, Spokane cancer treatment, Spokane oncology, Spokane oncologist, Spokane surgical oncology, Spokane surgical oncologist, Spokane Valley cancer center, Spokane Valley cancer treatment, Spokane Valley oncology, Spokane Valley oncologist, Spokane Valley surgical oncology, Eastern Washington Oncology.

Reviews

This listing was not reviewed yet:

Opening hours

Payment Options

Cash American Express Visa MasterCard Check Discover
  • Lumpectomy

    A lumpectomy, also known as breast-conserving surgery (BCS), is a surgical procedure to remove a cancerous tumor or abnormal tissue from the breast while preserving as much healthy breast tissue as possible. It is commonly used to treat early-stage breast cancer and certain precancerous breast conditions. The goal is to remove the cancer with a surrounding margin of healthy tissue while maintaining the natural appearance and shape of the breast. Lumpectomy is often followed by radiation therapy to reduce the risk of cancer recurrence.

  • Simple Mastectomy

    A simple mastectomy, also called a total mastectomy, is a surgical procedure that removes the entire breast, including the breast tissue, nipple and areola, and most of the overlying skin. Unlike a modified radical mastectomy, a simple mastectomy does not routinely remove the axillary (underarm) lymph nodes or the underlying chest muscles.

  • Skin-sparing Mastectomy

    A skin-sparing mastectomy is a breast cancer surgery that removes the breast tissue, nipple and areola, while preserving most of the natural breast skin. This approach allows the surgeon to maintain the breast's skin envelope, creating the foundation for breast reconstruction performed during the same operation or at a later time.

  • Nipple-sparing Mastectomy

    A nipple-sparing mastectomy is a breast cancer surgery that removes the breast tissue while preserving the breast skin, nipple, and areola. This approach maintains more of the breast's natural appearance and can provide a foundation for immediate or delayed breast reconstruction. A nipple-sparing mastectomy preserves these structures when it is medically appropriate and oncologically safe to do so.

  • Modified Radical Mastectomy

    A modified radical mastectomy is a breast cancer surgery that removes the entire breast, including the breast tissue, nipple, areola, and most of the overlying skin, along with lymph nodes in the underarm (axillary) region, while preserving the underlying chest muscles.

  • Radical Mastectomy

    A radical mastectomy is an extensive breast cancer surgery that removes the entire breast, including the breast tissue, nipple, areola, and overlying skin, as well as the axillary (underarm) lymph nodes and the underlying chest muscles (pectoralis major and pectoralis minor). Historically, this procedure was a standard treatment for breast cancer. Today, it is rarely performed because less extensive surgical approaches are generally equally effective for many patients while preserving more normal tissue.

  • Sentinel Node Biopsy

    A sentinel lymph node biopsy (SLNB) is a surgical procedure used to determine whether cancer has spread from a primary tumor to nearby lymph nodes. In breast cancer care, it involves identifying and removing the first one or few lymph nodes that receive lymphatic drainage from the breast. These are called sentinel lymph nodes because they are the first nodes where cancer cells are most likely to spread. This minimally invasive procedure helps determine the stage of breast cancer and whether additional lymph node treatment may be necessary.

  • Axillary Lymph Node Dissection

    An axillary lymph node dissection (ALND) is a surgical procedure that removes a group of lymph nodes from the underarm (axillary) region to determine whether breast cancer has spread beyond the breast and to help manage regional disease. Unlike a sentinel lymph node biopsy, which removes only a few targeted lymph nodes, an axillary lymph node dissection removes a larger number of nodes. The procedure may be performed during breast cancer surgery or as a separate operation, depending on the patient's treatment plan.

  • Targeted Axillary Dissection

    A targeted axillary dissection (TAD) is a breast cancer surgery that removes specific lymph nodes in the underarm (axillary) region to evaluate whether cancer remains after chemotherapy or other systemic treatment. The procedure combines a sentinel lymph node biopsy with the removal of a previously identified lymph node known to contain cancer. Targeted axillary dissection is commonly used for selected patients who had cancer-positive axillary lymph nodes before receiving treatment and whose lymph nodes show a favorable response to therapy. It can help assess treatment effectiveness while potentially avoiding a more extensive axillary lymph node dissection.

Categories

Oncology
(509)228-1000 (509)-228-1000 +15092281000 (800)866-9809 (800)-866-9809 +18008669809